1-3 of 3
Francisco J. Novo
Close
Sort by
Journal Articles

Lymphoma-Derived IL-10 Is a Key Immunomodulatory Factor at the Tumor Microenvironment of Activated B-Cell Diffuse Large B-Cell Lymphoma and Influences In Vivo Responses to Immunotherapy

Marcos Garcia-Lacarte, Sara C Grijalba, Francisco J Novo, Adrián Arnaiz-Leché, Javier Melchor, Marién Pascual, Enrique Goñi, Sandra Morales-Sánchez, María A Burrell, Oscar Blanco, Iñigo Clemente-Larramendi, Jose A Martinez-Climent, Noelia Casares, Juan J Lasarte, Pablo Sarobe, Miguel Canales, Sergio Roa
Journal: Blood
Blood (2023) 142 (Supplement 1): 716.
https://doi.org/10.1182/blood-2023-177612
Published: 2023
Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero
Journal: Blood
Blood (2010) 115 (3): 615–625.
https://doi.org/10.1182/blood-2009-06-227363
Published: 2010
Includes: Supplemental data
Journal Articles

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma

Brief Report
José I. Martı́n-Subero, Stefan Gesk, Lana Harder, Takashi Sonoki, Philip W. Tucker, Brigitte Schlegelberger, Werner Grote, Francisco J. Novo, Marı́a J. Calasanz, Martin L. Hansmann, Martin J. S. Dyer, Reiner Siebert
Journal: Blood
Blood (2002) 99 (4): 1474–1477.
https://doi.org/10.1182/blood.V99.4.1474
Published: 2002